Last reviewed · How we verify
Simulation agent of Yiqi Wenyang Jiedu prescription
Simulation agent of Yiqi Wenyang Jiedu prescription is a Small molecule drug developed by Jie Li. It is currently FDA-approved.
At a glance
| Generic name | Simulation agent of Yiqi Wenyang Jiedu prescription |
|---|---|
| Sponsor | Jie Li |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Simulation agent of Yiqi Wenyang Jiedu prescription CI brief — competitive landscape report
- Simulation agent of Yiqi Wenyang Jiedu prescription updates RSS · CI watch RSS
- Jie Li portfolio CI
Frequently asked questions about Simulation agent of Yiqi Wenyang Jiedu prescription
What is Simulation agent of Yiqi Wenyang Jiedu prescription?
Simulation agent of Yiqi Wenyang Jiedu prescription is a Small molecule drug developed by Jie Li.
Who makes Simulation agent of Yiqi Wenyang Jiedu prescription?
Simulation agent of Yiqi Wenyang Jiedu prescription is developed and marketed by Jie Li (see full Jie Li pipeline at /company/jie-li).
What development phase is Simulation agent of Yiqi Wenyang Jiedu prescription in?
Simulation agent of Yiqi Wenyang Jiedu prescription is FDA-approved (marketed).